The dysregulation of TFEB expression and activity has been implicated in the progression of various diseases, including Parkinson's disease, Alzheimer's disease, Huntington's disease, and RagCS75Y cardiomyopathy 36-39. Here, TFEB is linked to cardiomyopathy.